Day: November 21, 2019

STOCKHOLM – November 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announce today that its proprietary Master Annotation method has received patent protection in the U.S.The U.S. Patent and Trademark Office (USPTO) has granted a patent to ContextVision for this invention, titled “method and system for detecting pathological anomalies in a digital pathology image and method for annotating a tissue slide”.ContextVision developed this method to automatically and more objectively outline specific structures in pathology images used for training deep learning algorithms. It identifies and highlights cancer areas and other structures by using multi-plex immunofluorescent staining. This enables development of algorithms based on objective data with high accuracy.“This...

The Chairman of the Board of Per Aarsleff Holding A/S, Andreas Lundby, will not stand for re-election at the Annual General Meeting taking place on 30 January 2020. Andreas Lundby turns 70 years in 2020. He has been a member of the Board of Directors for 11 years and for the past six years he has been Chairman of the Board. The Board finds it increasingly important that professional and industry-related qualifications are represented in the Board and recommends that the former general manager of Per Aarsleff Holding A/S, Ebbe Malte Iversen, aged 68, is elected to the Board of Directors. Following the election, it is the intention of the Board to appoint Ebbe Malte Iversen as the new Chairman of the Board. Also, the Board of Directors recommends that the age limit is raised to 75 years.Director Nicolai Schultz, aged 51, is appointed as...

Bestyrelsesformand i Per Aarsleff Holding A/S, Andreas Lundby, genopstiller ikke til den kommende generalforsamling, som finder sted 30. januar 2020. Andreas Lundby fylder 70 år i 2020. Han har været bestyrelsesmedlem i 11 år, heraf de seneste seks år som formand. Bestyrelsen lægger i stigende grad vægt på, at faglige og branchemæssige kompetencer er repræsenteret i bestyrelsen og indstiller forhenværende administrerende direktør i Per Aarsleff Holding A/S Ebbe Malte Iversen, 68 år, til indvalg. I givet fald er det bestyrelsens hensigt at konstituere sig med Ebbe Malte Iversen som ny formand. Bestyrelsen indstiller i øvrigt, at aldersgrænsen hæves til 75 år.Direktør Nicolai Schultz, 51 år, udnævnes til nyt medlem af direktionen i Per Aarsleff Holding A/S pr. 1. januar 2020. Nicolai Schultz blev i februar 2019 ansat som direktør med særligt...

NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) — Con Edison received two prestigious industry awards from PA Consulting at its national ReliabilityOne™ conference held in Austin last night: the 2019 Outstanding Customer Reliability Experience Award, as well as the organization’s Award for Outstanding Reliability in the Northeast Region.The Customer Reliability Experience Award is presented to the recipient who has the best overall customer approach and ongoing strategy to seek innovative methods of involving and engaging customers, seizing the opportunity to deliver a positive shift in conveying accurate, timely information; the regional reliability awards are presented annually to utilities achieving outstanding reliability performance in delivering the most reliable electric service to customers.“These awards are a tribute to the hardworking...

BANNOCKBURN, Ill., Nov. 21, 2019 (GLOBE NEWSWIRE) — Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate treatment site infusion therapy services, will present at the Bank of America Merrill Lynch 2019 Leveraged Finance Conference on December 3, 2019. Mike Shapiro, Option Care Health’s Chief Financial Officer, is scheduled to present at 10:50 a.m. ET. A live audio webcast and replay of this presentation will be available at https://investors.optioncarehealth.com.About Option Care HealthOption Care Health, Inc. (Option Care Health) (NASDAQ: BIOS), is the nation’s largest independent provider of home and alternate site infusion services. With over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions...

JERSEY CITY, N.J., Nov. 21, 2019 (GLOBE NEWSWIRE) — Verisk (Nasdaq:VRSK), a leading data analytics provider, announced today the launch of OneXperienceä, a new InsurTech solution that enables digital engagement between policyholders and their insurers during a critical underwriting step—the home inspection.Traditional home inspections, conducted after coverage is bound, can be intrusive for customers, costly for insurers, and time-consuming for everyone involved. And a completed inspection may still miss valuable information. OneXperience helps insurers gain quick, cost-effective access to accurate, current risk data on properties and their contents—without compromising the customer experience—to price and underwrite homeowners policies correctly.“Many insurance consumers today are looking for easy digital interactions when they...

TORONTO, Nov. 21, 2019 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a growth‐focused gold exploration and development company, announces recent soil sampling results and the expansion of the Company’s land position at the Beartrack-Arnett Gold Project located in Lemhi County, Idaho.  “Systematic exploration by Revival Gold’s technical team continues to advance our understanding of the geology at Beartrack-Arnett and identify new gold targets for future drilling,” said Hugh Agro, President & CEO.Revival Gold’s 2019 soil sample program consisted of 971 samples collected on a 150-meter by 100-meter grid over 12 square kilometers. Samples were collected and processed using a partial leach to enable identification of potential anomalies under post-mineral cover.A preliminary...

First 10 checkpoint-refractory melanoma patients treatedEstablished safety profiles of PV-10 and KEYTRUDA were maintained20% ORR and 40% DCR (RECIST 1.1)Changes in immune system activation biomarkers of checkpoint-refractory patients were similar to those of single-agent PV-10- and PV-10+KEYTRUDA-treated checkpoint-naïve patientsKNOXVILLE, TN, Nov. 21, 2019 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that data from the Company’s ongoing Phase 1b/2 study of lysosomal-targeting cancer immunotherapy PV-10 (rose bengal disodium) in combination with KEYTRUDA (pembrolizumab) for the treatment of checkpoint inhibition-refractory advanced cutaneous melanoma patients were presented at the 16th International Congress of the Society for Melanoma Research (SMR 2019 Congress), held in Salt Lake City, Utah from November 20-24,...

Knight receives exclusive license to commercialize rigosertib in Canada

REGULATED INFORMATIONAvailability of the Fiscal 2019 Universal Registration DocumentIssy-les-Moulineaux, November 21, 2019 – Sodexo’s Fiscal 2019 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) on November 20, 2019.In accordance with applicable regulations, it is available on Sodexo’s website (www.sodexo.com > Finance > Regulated information) and on the AMF’s website (www.amf-france.org).This Universal Registration Document includes, in particular:The statutory financial statements of Sodexo S.A. for Fiscal 2019;The consolidated financial statements of the Group for Fiscal 2019;The related auditors’ reports on the statutory and the consolidated financial statements;The 2018-2019 management report including the declaration on extra-financial performance;The Board of Directors’ report on corporate...